BA vs TMO: Which Is the Better Buy?
Side-by-side comparison of The Boeing Company and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-07.
The Boeing Company · Industrials
$234.54
+45.0% upside to fair value
Grade C
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
BA has more upside to fair value
(+45.0%).
TMO trades at a lower forward P/E
(25.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BA |
TMO |
| Current Price |
$234.54 |
$464.61 |
| Fair Value Estimate |
$340.08 |
$498.27 |
| Upside to Fair Value |
+45.0%
|
+7.2%
|
| Market Cap |
$184.9B |
$172.7B |
| Forward P/E |
96.9x
|
25.2x
|
| EV / EBITDA |
30.4x
|
19.1x
|
| Price / Sales |
2.0x
|
3.8x
|
| Price / FCF |
-177.6x
|
25.6x
|
| Revenue Growth YoY |
+14.0%
|
+6.2%
|
| Gross Margin |
4.8%
|
39.4%
|
| Operating Margin |
-5.9%
|
17.8%
|
| Return on Equity |
-8723.1%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
The Boeing Company operates in the Industrials sector within the Aerospace & Defense industry, manufacturing commercial jetliners, defense, space, and security systems. Despite a challenging operating margin of -5.9% and a negative free cash flow per share of -2.46, Boeing shows strong recent earnings growth of 89.2% and revenue growth of 14.0% in the most recent quarter, signaling a potential re…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
BA |
TMO |
| Zone Low |
$255.06 |
$373.70 |
| Zone High |
$289.07 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|